000 | 01109 a2200301 4500 | ||
---|---|---|---|
005 | 20250518060815.0 | ||
264 | 0 | _c20190919 | |
008 | 201909s 0 0 jpn d | ||
022 | _a1881-6096 | ||
024 | 7 |
_a10.11477/mf.1416201387 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aOkamoto, Tomoko | |
245 | 0 | 0 |
_a[Parkinson's Disease: amantadine, zonisamide, dabrafenib]. _h[electronic resource] |
260 |
_bBrain and nerve = Shinkei kenkyu no shinpo _cSep 2019 |
||
300 |
_a953-959 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 |
_aAmantadine _xtherapeutic use |
650 | 0 | 4 |
_aAntiparkinson Agents _xtherapeutic use |
650 | 0 | 4 | _aDrug Repositioning |
650 | 0 | 4 | _aGenome-Wide Association Study |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImidazoles _xtherapeutic use |
650 | 0 | 4 |
_aOximes _xtherapeutic use |
650 | 0 | 4 |
_aParkinson Disease _xdrug therapy |
650 | 0 | 4 |
_aZonisamide _xtherapeutic use |
773 | 0 |
_tBrain and nerve = Shinkei kenkyu no shinpo _gvol. 71 _gno. 9 _gp. 953-959 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.11477/mf.1416201387 _zAvailable from publisher's website |
999 |
_c30097633 _d30097633 |